Loading clinical trials...
Loading clinical trials...
A Multi-center, Randomized, Open-label, Active-controlled, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of EzetimiBe/Rosuvastatin Diabetic Dislipidemia With Hypertriglyceridaemia
Conditions
Interventions
Rosuzet tablet 10/5 mg (Ezetimibe 10 mg/Rosuvastatin 5 mg)
Suvast tablet 10 mg (Rosuvastatin 10 mg)
Locations
26
South Korea
Korea University Ansan Hospital
Ansan, South Korea
Soon Chun Hyang University Hospital Bucheon
Bucheon-si, South Korea
Soon Chun Hyang University Hospital Cheonan
Cheonan, South Korea
Keimyung University Dongsan Medical Center
Daegu, South Korea
Yeongnam University Medical Center
Daegu, South Korea
Eulji University Hospital
Daejeon, South Korea
Start Date
January 3, 2020
Primary Completion Date
May 28, 2021
Completion Date
February 13, 2024
Last Updated
August 14, 2025
NCT07081997
NCT06513026
NCT06329375
NCT06945406
NCT06959901
NCT06574035
Lead Sponsor
Seoul National University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions